T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors
AM Tsimberidou, K Van Morris, HH Vo, S Eck… - Journal of Hematology & …, 2021 - Springer
Abstract T-cell receptor (TCR)-based adoptive therapy employs genetically modified
lymphocytes that are directed against specific tumor markers. This therapeutic modality …
lymphocytes that are directed against specific tumor markers. This therapeutic modality …
A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells
N Mochizuki, S Shimizu, T Nagasawa… - Blood, The Journal …, 2000 - ashpublications.org
Abstract The reciprocal translocation t (1; 3)(p36; q21) occurs in a subset of myelodysplastic
syndrome (MDS) and acute myeloid leukemia (AML), which is frequently characterized by …
syndrome (MDS) and acute myeloid leukemia (AML), which is frequently characterized by …
Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers
T Weinschenk, M Andrea, J Fritsche… - US Patent App. 15 …, 2017 - Google Patents
First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
52630910&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
52630910&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
Interaction of microtubule-associated protein-2 and p63: a new link between microtubules and rough endoplasmic reticulum membranes in neurons
C Abi Farah, D Liazoghli, S Perreault… - Journal of Biological …, 2005 - ASBMB
Neurons are polarized cells presenting two distinct compartments, dendrites and an axon.
Dendrites can be distinguished from the axon by the presence of rough endoplasmic …
Dendrites can be distinguished from the axon by the presence of rough endoplasmic …
Peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
T Weinschenk, M Andrea, J Fritsche, P Mueller… - US Patent …, 2018 - Google Patents
The present invention relates to peptides, proteins, nucleic acids and cells for use in
immunotherapeutic methods. In particular, the present invention relates to the …
immunotherapeutic methods. In particular, the present invention relates to the …
Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers
T Weinschenk, M Andrea, J Fritsche… - US Patent App. 16 …, 2019 - Google Patents
First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
52630910&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
52630910&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers
T Weinschenk, M Andrea, J Fritsche… - US Patent App. 15 …, 2018 - Google Patents
A method of treating a patient who has a cancer includes administering to said patient a
composition containing a population of activated T cells that selectively recognize the cancer …
composition containing a population of activated T cells that selectively recognize the cancer …
Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers
T Weinschenk, M Andrea, J Fritsche… - US Patent App. 17 …, 2020 - Google Patents
First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
52630910&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
52630910&utm_source= google_patent&utm_medium= platform_link&utm_campaign …
Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers
T Weinschenk, M Andrea, J Fritsche… - US Patent App. 16 …, 2020 - Google Patents
The present invention relates to peptides, proteins, nucleic acids and cells for use in
immunotherapeutic methods. In particular, the present invention relates to the …
immunotherapeutic methods. In particular, the present invention relates to the …
Method of eliciting a CD8+ cytotoxic response in hepatocellular carcinoma patients with a population of activated T cells
T Weinschenk, M Andrea, J Fritsche, P Mueller… - US Patent …, 2023 - Google Patents
2022-06-29 Assigned to IMMATICS BIOTECHNOLOGIES GMBH reassignment IMMATICS
BIOTECHNOLOGIES GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
BIOTECHNOLOGIES GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …